BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3011551)

  • 1. Strategies for the inhibition of neuropeptide-metabolizing enzymes.
    Turner AJ
    Biochem Soc Trans; 1986 Apr; 14(2):399-401. PubMed ID: 3011551
    [No Abstract]   [Full Text] [Related]  

  • 2. Are there neuropeptide-specific peptidases?
    Turner AJ; Matsas R; Kenny AJ
    Biochem Pharmacol; 1985 May; 34(9):1347-56. PubMed ID: 2986644
    [No Abstract]   [Full Text] [Related]  

  • 3. Intramembrane proteolysis.
    Wolfe MS
    Chem Rev; 2009 Apr; 109(4):1599-612. PubMed ID: 19226105
    [No Abstract]   [Full Text] [Related]  

  • 4. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
    Checler F; Vincent JP; Kitabgi P
    J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme).
    Hooper NM; Kenny AJ; Turner AJ
    Biochem J; 1985 Oct; 231(2):357-61. PubMed ID: 2998348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of neuropeptides at brain and pituitary sites.
    Edwardson JA; McDermott JR
    Biochem Soc Trans; 1985 Feb; 13(1):50-3. PubMed ID: 3888723
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide-metabolizing peptidases in neuro-2a neuroblastoma and C6 glioma cells.
    Del Bel EA; Gambarini AG; Martins AR
    J Neurochem; 1986 Sep; 47(3):938-44. PubMed ID: 3016193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hatching enzyme of the solitary Ascidian, Halocynthia roretzi.
    Hoshi M; Numakunai T
    Acta Embryol Morphol Exp (Halocynthia Assoc); 1981 Dec-1982 Jan; 2(3):163-9. PubMed ID: 6756008
    [No Abstract]   [Full Text] [Related]  

  • 9. Common feature of the four types of protease mechanism.
    Polgár L
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():327-31. PubMed ID: 2205242
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammalian metalloendopeptidases.
    Bond JS; Beynon RJ
    Int J Biochem; 1985; 17(5):565-74. PubMed ID: 3896890
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea pig small intestine.
    Nau R; Schäfer G; Deacon CF; Cole T; Agoston DV; Conlon JM
    J Neurochem; 1986 Sep; 47(3):856-64. PubMed ID: 2426410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.
    Parvathy S; Oppong SY; Karran EH; Buckle DR; Turner AJ; Hooper NM
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):37-43. PubMed ID: 9355732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema with renin angiotensin system drugs and neutral endopeptidase inhibitors.
    Kostis JB; Moreyra AE; Kostis WJ
    J Am Soc Hypertens; 2016 May; 10(5):387-9. PubMed ID: 27005996
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE).
    Melzig MF; Pieper S; Siems WE; Heder G; Bóttger A; Liberra K; Lindequist U
    Pharmazie; 1996 Jul; 51(7):501-3. PubMed ID: 8774843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of bradykinin by peptidases in the lung.
    Dragović T; Igić R; Erdös EG; Rabito SF
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1491-6. PubMed ID: 8389109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biochemistry of the proteinases of eucaryotic microorganisms.
    North MJ
    Microbiol Rev; 1982 Sep; 46(3):308-40. PubMed ID: 6813664
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation and metabolism of neuropeptides.
    McKelvy JF; Blumberg S
    Annu Rev Neurosci; 1986; 9():415-34. PubMed ID: 2423009
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.